Microbiome profile of the most abundant phyla in one patient (Patient 1), across 12 infliximab treatments (-1 is the week before treatment, -2 the two weeks before treatment, etc). by Katrine Carlsen (5477300)

Subjects:

S1 Data - by Du Siqi (20721422)

Subjects:

Weather conditions and variation in the numbers of female <i>Ae. aegypti</i> captured in SAGO traps. by Jesús A. Aguilar-Durán (9931967)

Subjects:

Schematic diagram of simulated marine environment in Qingdao sea area. by Du Siqi (20721422)

Subjects:

Comparison of the depth estimation results of different methods under waveguide conditions in shallow waters of Qingdao. by Du Siqi (20721422)

Subjects:

Average number of female <i><i>Ae</i></i>. <i><i>aegypti</i></i> in SAGOs traps per trap per week before and after treatments. by Jesús A. Aguilar-Durán (9931967)

Subjects:

S5 Fig - by Katrine Carlsen (5477300)

Subjects:

Summary statistics for analysis of single family clades. by Katrine Carlsen (5477300)

Subjects:

Mode separation results of different methods in Qingdao shallow sea waveguide conditions. by Du Siqi (20721422)

Subjects:

S1 File - by Du Siqi (20721422)

Subjects:

Results of different Warping transform corrections for negative sound velocity gradient profiles. by Du Siqi (20721422)

Subjects:

Mode separation results of different methods in Qingdao shallow sea waveguide conditions. by Du Siqi (20721422)

Subjects:

STORMS microbiome reporting checklist. by Katrine Carlsen (5477300)

Subjects:

Pekeris waveguide schematic of the simulated marine environment. by Du Siqi (20721422)

Subjects:

Between the PCSO-524 group and the placebo group unpaired comparisons of the change between visits of quality of life and respiratory variables scores. by Nattapon Riengvirodkij (11268720)

Subjects:

A flow diagram outlining the number of dogs in each group during the study (visit 1 = day 0, visit 2 = day 35, and visit 3 = day 70). by Nattapon Riengvirodkij (11268720)

Subjects:

Distribution of quality of life and respiratory variables scores of all 3 visits (visit = day 0, visit 2 = day 35, and visit 3 = day 70) of the PCSO-524 group and the placebo group... by Nattapon Riengvirodkij (11268720)

Subjects:

The baseline characteristics of classifications and body condition score of the 2 groups (frequencies) at entry (visit 1, day 0). by Nattapon Riengvirodkij (11268720)

Subjects:

Distribution of continuous variables of all 3 visits (visit 1 = day 0, visit 2 = day 35, and visit 3 = day 70) of the PCSO-524 group and the placebo group. Results are shown as mea... by Nattapon Riengvirodkij (11268720)

Subjects:

Tricuspid regurgitation pressure gradient of all 17 dogs. by Nattapon Riengvirodkij (11268720)

Subjects: